103 related articles for article (PubMed ID: 20851012)
1. Gruppo Italiano di Studio sulle Infezioni Gravi - GISIG 3: controversial issues of severe bacterial infections due to multidrug-resistant Gram-positive bacteria: introduction by the National Coordinators.
Ippolito G; Moroni M; Carosi G
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S1. PubMed ID: 20851012
[No Abstract] [Full Text] [Related]
2. Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis.
Boumis E; Gesu G; Menichetti F; Ranieri M; Rinaldi M; Suter F; Nicastri E; Lauria FN; Carosi G; Moroni M; Ippolito G;
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S23-38. PubMed ID: 20843723
[TBL] [Abstract][Full Text] [Related]
3. Consensus document on controversial issues for the treatment of hospital-associated pneumonia.
Franzetti F; Antonelli M; Bassetti M; Blasi F; Langer M; Scaglione F; Nicastri E; Lauria FN; Carosi G; Moroni M; Ippolito G;
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S55-65. PubMed ID: 20863734
[TBL] [Abstract][Full Text] [Related]
4. Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology.
Lauria FN; De Carli G; Nicastri E
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S13-7. PubMed ID: 20843720
[TBL] [Abstract][Full Text] [Related]
5. Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.
Pan A; Cauda R; Concia E; Esposito S; Sganga G; Stefani S; Nicastri E; Lauria FN; Carosi G; Moroni M; Ippolito G;
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S39-53. PubMed ID: 20851013
[TBL] [Abstract][Full Text] [Related]
6. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G; Rossolini GM
Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
[TBL] [Abstract][Full Text] [Related]
7. Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses.
Arlotti M; Grossi P; Pea F; Tomei G; Vullo V; De Rosa FG; Di Perri G; Nicastri E; Lauria FN; Carosi G; Moroni M; Ippolito G;
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S79-92. PubMed ID: 20846891
[TBL] [Abstract][Full Text] [Related]
8. Gram-positive bacterial resistance: future treatment options.
Bassetti M; Melica G; Di Biagio A; Rosso R; Gatti G; Bassetti D
Curr Opin Investig Drugs; 2003 Aug; 4(8):944-52. PubMed ID: 14508878
[TBL] [Abstract][Full Text] [Related]
9. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.
Pea F; Viale P
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):255-70. PubMed ID: 17402840
[TBL] [Abstract][Full Text] [Related]
11. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
12. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
13. An overview of antimicrobial susceptibility patterns of gram-positive bacteria from National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
Mootsikapun P; Trakulsomboon S; Sawanpanyalert P; Aswapokee N; Suankratay C
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S87-90. PubMed ID: 21294504
[TBL] [Abstract][Full Text] [Related]
14. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections.
Leone S; Borrè S; Monforte Ad; Mordente G; Petrosillo N; Signore A; Venditti M; Viale P; Nicastri E; Lauria FN; Carosi G; Moroni M; Ippolito G;
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S67-77. PubMed ID: 20843721
[TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Wroblewska MM; Rudnicka J; Marchel H; Luczak M
Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
[TBL] [Abstract][Full Text] [Related]
16. Microbiology and drug resistance mechanisms of fully resistant pathogens.
Walsh FM; Amyes SG
Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
[TBL] [Abstract][Full Text] [Related]
17. Healthcare-acquired infections due to Gram-positive bacteria.
Bryant KA; Woods CR
Pediatr Infect Dis J; 2008 May; 27(5):455-6. PubMed ID: 18520341
[No Abstract] [Full Text] [Related]
18. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
Kuo LC; Yu CJ; Kuo ML; Chen WN; Chang CK; Lin HI; Chen CC; Lu MC; Lin CH; Hsieh WF; Chen LW; Chou Y; Huang MS; Lee CH; Chen SC; Thai SL; Chen PC; Chen CH; Tseng CC; Chen YS; Hsiue TR; Hsueh PR
Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
